Progyny, Inc. (PGNY) shareholders
PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 21/305% below fair value
$36.18−0.40 (-1.09%)
Close on Nov 13, 2026Market cap $2.78BP/E 33.2Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
79M of 77M shares
Institutional holders
311
67 new, 44 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 38 sales
Net sold $24.51M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 11,294,526 | 14.70% | 13G (passive) amendment | Sep 30, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (8.90%) | 7,004,280 | 8.90% | 13G (passive) amendment | Jun 30, 2026 |
| Vanguard Portfolio Management | 5,357,311 | 6.54% | 13G (passive) | Mar 31, 2026 |
| Thrivent Financial For Lutherans | 5,350,869 | 6.30% | 13G (passive) | Mar 31, 2025 |
| FMR LLC Joint filing with Abigail P. Johnson (5.50%) | 4,712,613 | 5.50% | 13G (passive) | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PGNY | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11,599,921 | 15.12% | $334.43M | −398,546 | 0.00% |
| FMR LLC | 7,004,280 | 9.13% | $201.93M | +503,461 | 0.01% |
| Vanguard Portfolio Management LLC | 5,019,465 | 6.54% | $144.71M | −272,563 | 0.01% |
| Vanguard Capital Management LLC | 3,210,723 | 4.18% | $92.57M | −270,616 | 0.00% |
| State Street Corp | 3,022,859 | 3.94% | $87.15M | −57,434 | 0.00% |
| Ameriprise Financial Inc | 2,763,514 | 3.60% | $79.67M | −61,817 | 0.02% |
| Fort Washington Investment Advisors Inc /Oh/ | 2,548,164 | 3.32% | $73.46M | −145,229 | 0.37% |
| Geode Capital Management, LLC | 1,969,208 | 2.57% | $56.78M | −73,757 | 0.00% |
| Citadel Advisors LLC | 1,785,717 | 2.33% | $51.48M | New | 0.01% |
| Dimensional Fund Advisors LP | 1,688,670 | 2.20% | $48.68M | +115,245 | 0.01% |
| Soleus Capital Management, L.P. | 1,602,000 | 2.09% | $46.19M | −465,000 | 1.59% |
| Morgan Stanley | 1,535,897 | 2.00% | $44.28M | −751,720 | 0.00% |
| Wellington Management Group Llp | 1,496,633 | 1.95% | $43.15M | −790,748 | 0.01% |
| Disciplined Growth Investors Inc /Mn | 1,181,632 | 1.54% | $34.07M | +607,066 | 0.58% |
| Loomis Sayles & Co L P | 1,080,928 | 1.41% | $31.16M | +92,538 | 0.04% |
| Baillie Gifford & Co | 1,078,629 | 1.41% | $31.10M | −142,100 | 0.03% |
| Jane Street Group, LLC | 1,063,363 | 1.39% | $30.66M | +914,457 | 0.00% |
| Easterly Investment Partners LLC | 958,117 | 1.25% | $27.62M | +124,669 | 1.41% |
| Charles Schwab Investment Management Inc | 954,065 | 1.24% | $27.51M | +155,441 | 0.00% |
| Fideuram Asset Management (Ireland) dac | 904,062 | 1.18% | $18.39M | +823,237 | 0.35% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 311 | 79M | 100.0% | 67 / 86 | 119 / 44 | 12M | 13M |
| Q1 2026 | 293 | 80M | 100.0% | 48 / 117 | 86 / 64 | 24M | 14M |
| Q4 2025 | 314 | 80M | 100.0% | 62 / 96 | 123 / 47 | 10M | 14M |
| Q3 2025 | 301 | 84M | 100.0% | 39 / 138 | 85 / 35 | 10M | 8M |
| Q2 2025 | 302 | 82M | 100.0% | 49 / 106 | 113 / 34 | 12M | 7M |
| Q1 2025 | 288 | 77M | 100.0% | 64 / 90 | 95 / 36 | 23M | 29M |
| Q4 2024 | 264 | 83M | 100.0% | 55 / 76 | 97 / 74 | 15M | 18M |
| Q3 2024 | 285 | 87M | 100.0% | 59 / 100 | 96 / 96 | 33M | 26M |
| Q2 2024 | 325 | 92M | 100.0% | 60 / 113 | 108 / 55 | 16M | 18M |
| Q1 2024 | 324 | 94M | 100.0% | 59 / 120 | 105 / 49 | 14M | 19M |
| Q4 2023 | 317 | 100M | 100.0% | 45 / 132 | 105 / 44 | 19M | 7M |
| Q3 2023 | 321 | 93M | 100.0% | 46 / 146 | 86 / 32 | 10M | 7M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
302 funds held PGNY in Q2 2026, 52% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PGNY | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 4,389,886 | 5.72% | $126.56M | 0.11% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 2,242,829 | 2.92% | $64.66M | 0.00% | Jun 30, 2026 |
| Touchstone Strategic Trust-Touchstone Small Company Fund | 1,940,666 | 2.53% | $55.95M | 3.25% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,754,502 | 2.29% | $50.58M | 0.06% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund | 1,676,019 | 2.18% | $52.17M | 0.59% | Jul 31, 2026 |
| Vanguard Small-Cap Index Fund | 1,615,571 | 2.11% | $46.58M | 0.02% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 927,416 | 1.21% | $26.74M | 0.06% | Jun 30, 2026 |
| Fidelity Small Cap Growth K6 Fund | 849,341 | 1.11% | $26.44M | 0.58% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 836,256 | 1.09% | $24.11M | 0.02% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 746,912 | 0.97% | $23.25M | 0.07% | Jul 31, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 714,501 | 0.93% | $18.26M | 0.01% | May 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 669,779 | 0.87% | $19.31M | 0.11% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 654,642 | 0.85% | $18.87M | 0.23% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 630,790 | 0.82% | $18.19M | 0.12% | Jun 30, 2026 |
| Fidelity Small Cap Discovery Fund | 557,620 | 0.73% | $17.36M | 0.76% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David J. Schlanger | Executive Chairman, Director | 245,356 | 0.32% | Nov 12, 2026 |
| Peter Anevski | CHIEF EXECUTIVE OFFICER, Director | 710,973 | 0.93% | Nov 12, 2026 |
| Geoffrey Clapp | Chief Product Officer | 58,235 | 0.08% | Nov 13, 2026 |
| Mark S. Livingston | CHIEF FINANCIAL OFFICER | 70,314 | 0.09% | Nov 6, 2026 |
| Allison Swartz | EVP, GC | 83,976 | 0.11% | Nov 4, 2026 |
| Melissa B. Cummings | Chief Operating Officer | 66,496 | 0.09% | Oct 16, 2026 |
| Michael E. Sturmer | PRESIDENT | 255,205 | 0.33% | Jan 5, 2026 |
| Kevin K. Gordon | Director | 33,319 | 0.04% | Sep 18, 2026 |
| Cheryl Scott | Director | 34,439 | 0.04% | Jun 3, 2026 |
| Lloyd H. Dean | Director | 26,519 | 0.03% | May 26, 2026 |
| Elizabeth D. Bierbower | Director | 5,660 | 0.01% | May 26, 2026 |
| Roger C. Holstein | Director | 28,729 | 0.04% | May 26, 2026 |
| Debra L. Morris | Director | 5,660 | 0.01% | May 26, 2026 |
| Jeffrey G. Park | Director | 39,981 | 0.05% | May 26, 2026 |
| Norman Payson | Director | 343,712 | 0.45% | May 26, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Geoffrey Clapp Chief Product Officer | Nov 11, 2026 | Sale(10b5-1 plan) | −774 | $36.41 | $28.18K | 58,235 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 10, 2026 | Sale(10b5-1 plan) | −18,059 | $36.29 | $655.27K | 710,972 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 10, 2026 | Sale(10b5-1 plan) | −33,437 | $35.61 | $1.19M | 729,031 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 10, 2026 | Sale(10b5-1 plan) | −64,921 | $36.29 | $2.36M | 762,468 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 10, 2026 | Sale(10b5-1 plan) | −120,213 | $35.61 | $4.28M | 827,389 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 10, 2026 | Option exercise | +185,134 | $0.91 | $168.47K | 947,602 |
| David J. Schlanger Executive Chairman, Director | Nov 10, 2026 | Sale(10b5-1 plan) | −35,392 | $35.36 | $1.25M | 238,462 |
| David J. Schlanger Executive Chairman, Director | Nov 10, 2026 | Option exercise | +35,392 | $0.91 | $32.21K | 273,854 |
| David J. Schlanger Executive Chairman, Director | Nov 9, 2026 | Sale(10b5-1 plan) | −161,208 | $35.73 | $5.76M | 238,462 |
| David J. Schlanger Executive Chairman, Director | Nov 9, 2026 | Option exercise | +161,208 | $0.91 | $146.70K | 399,670 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 9, 2026 | Sale(10b5-1 plan) | −35,104 | $35.73 | $1.25M | 762,468 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 9, 2026 | Sale(10b5-1 plan) | −126,204 | $35.73 | $4.51M | 797,572 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 9, 2026 | Option exercise | +126,204 | $0.91 | $114.85K | 923,776 |
| David J. Schlanger Executive Chairman, Director | Nov 5, 2026 | Sale(10b5-1 plan) | −3,400 | $35.22 | $119.75K | 238,462 |
| David J. Schlanger Executive Chairman, Director | Nov 5, 2026 | Option exercise | +3,400 | $0.91 | $3.09K | 241,862 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 5, 2026 | Sale(10b5-1 plan) | −8,539 | $35.09 | $299.64K | 797,572 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 5, 2026 | Sale(10b5-1 plan) | −3,400 | $35.23 | $119.77K | 806,111 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Nov 5, 2026 | Option exercise | +3,400 | $0.91 | $3.09K | 809,511 |
| Mark S. Livingston CHIEF FINANCIAL OFFICER | Nov 4, 2026 | Sale(10b5-1 plan) | −2,139 | $30.00 | $64.17K | 70,314 |
| Allison Swartz EVP, GC | Nov 2, 2026 | Award | +8,160 | – | – | 83,976 |
| Melissa B. Cummings Chief Operating Officer | Oct 14, 2026 | Sale(10b5-1 plan) | −1,879 | $28.00 | $52.61K | 66,496 |
| Melissa B. Cummings Chief Operating Officer | Oct 14, 2026 | Tax withholding | −1,559 | $27.39 | $42.70K | 68,375 |
| Allison Swartz EVP, GC | Sep 23, 2026 | Sale(10b5-1 plan) | −3,903 | $26.10 | $101.87K | 75,816 |
| Geoffrey Clapp Chief Product Officer | Sep 17, 2026 | Tax withholding | −819 | $27.38 | $22.42K | 59,009 |
| Kevin K. Gordon Director | Sep 10, 2026 | Tax withholding | −10,500 | $27.24 | $286.02K | 18,292 |
| Kevin K. Gordon Director | Sep 10, 2026 | Option exercise | +22,000 | $13.00 | $286.00K | 28,792 |
| Kevin K. Gordon Director | Sep 10, 2026 | Sale | −11,500 | $27.12 | $311.88K | 6,792 |
| Kevin K. Gordon Director | Sep 10, 2026 | Tax withholding | −10,500 | $27.24 | $286.02K | 18,292 |
| Kevin K. Gordon Director | Sep 10, 2026 | Sale | −11,500 | $27.94 | $321.31K | 6,792 |
| Kevin K. Gordon Director | Sep 10, 2026 | Option exercise | +22,000 | $13.00 | $286.00K | 28,792 |
| Allison Swartz EVP, GC | Sep 4, 2026 | Tax withholding | −479 | $26.61 | $12.75K | 79,719 |
| Mark S. Livingston CHIEF FINANCIAL OFFICER | Sep 4, 2026 | Tax withholding | −479 | $26.61 | $12.75K | 72,453 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Sep 3, 2026 | Tax withholding | −5,361 | $26.29 | $140.94K | 806,111 |
| Allison Swartz EVP, GC | Sep 3, 2026 | Tax withholding | −828 | $26.29 | $21.77K | 80,198 |
| Mark S. Livingston CHIEF FINANCIAL OFFICER | Sep 3, 2026 | Tax withholding | −1,532 | $26.29 | $40.28K | 72,932 |
| Mark S. Livingston CHIEF FINANCIAL OFFICER | Sep 2, 2026 | Tax withholding | −224 | $25.66 | $5.75K | 74,464 |
| Allison Swartz EVP, GC | Aug 28, 2026 | Tax withholding | −1,352 | $25.86 | $34.96K | 81,026 |
| Melissa B. Cummings Chief Operating Officer | Jul 14, 2026 | Sale(10b5-1 plan) | −2,244 | $31.60 | $70.91K | 69,934 |
| Melissa B. Cummings Chief Operating Officer | Jul 14, 2026 | Tax withholding | −1,193 | $31.98 | $38.15K | 72,178 |
| Geoffrey Clapp Chief Product Officer | Jun 17, 2026 | Tax withholding | −819 | $26.60 | $21.79K | 59,828 |
| Allison Swartz EVP, GC | Jun 4, 2026 | Sale(10b5-1 plan) | −599 | $25.08 | $15.02K | 82,378 |
| Allison Swartz EVP, GC | Jun 4, 2026 | Tax withholding | −339 | $24.99 | $8.47K | 82,977 |
| Mark S. Livingston CHIEF FINANCIAL OFFICER | Jun 4, 2026 | Sale(10b5-1 plan) | −1,918 | $25.50 | $48.91K | 75,287 |
| Mark S. Livingston CHIEF FINANCIAL OFFICER | Jun 4, 2026 | Sale(10b5-1 plan) | −599 | $25.50 | $15.27K | 74,688 |
| Mark S. Livingston CHIEF FINANCIAL OFFICER | Jun 4, 2026 | Tax withholding | −339 | $24.99 | $8.47K | 77,205 |
| Allison Swartz EVP, GC | Jun 3, 2026 | Tax withholding | −676 | $25.12 | $16.98K | 84,515 |
| Allison Swartz EVP, GC | Jun 3, 2026 | Sale(10b5-1 plan) | −1,199 | $25.02 | $30.00K | 83,316 |
| Peter Anevski CHIEF EXECUTIVE OFFICER, Director | Jun 3, 2026 | Tax withholding | −5,361 | $25.12 | $134.67K | 811,472 |
| Mark S. Livingston CHIEF FINANCIAL OFFICER | Jun 3, 2026 | Tax withholding | −1,082 | $25.12 | $27.18K | 77,544 |
| Geoffrey Clapp Chief Product Officer | Jun 2, 2026 | Sale | −1,530 | $25.58 | $39.14K | 59,117 |
| Geoffrey Clapp Chief Product Officer | Jun 2, 2026 | Tax withholding | −11,379 | $25.54 | $290.62K | 60,647 |
| Geoffrey Clapp Chief Product Officer | Jun 2, 2026 | Option exercise | +12,909 | $20.91 | $269.93K | 72,026 |
| Mark S. Livingston CHIEF FINANCIAL OFFICER | Jun 2, 2026 | Tax withholding | −158 | $26.20 | $4.14K | 78,905 |
| Mark S. Livingston CHIEF FINANCIAL OFFICER | Jun 2, 2026 | Sale(10b5-1 plan) | −279 | $26.20 | $7.31K | 78,626 |
| Cheryl Scott Director | Jun 1, 2026 | Option exercise | +14,667 | $13.00 | $190.67K | 34,439 |
| Cheryl Scott Director | Jun 1, 2026 | Tax withholding | −7,228 | $26.38 | $190.67K | 27,211 |
| Cheryl Scott Director | Jun 1, 2026 | Sale | −7,439 | $26.39 | $196.32K | 19,772 |
| Allison Swartz EVP, GC | May 28, 2026 | Sale(10b5-1 plan) | −2,398 | $25.46 | $61.05K | 85,191 |
| Allison Swartz EVP, GC | May 28, 2026 | Tax withholding | −1,352 | $25.48 | $34.45K | 87,589 |
| Kevin K. Gordon Director | May 27, 2026 | Other | +2,526 | – | – | 15,027 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
6.37%
5M shares short
Days to cover
6.3
At 1M shares a day
Change since last report
-1.9%
From 5M shares
Short volume, 20 days
60.1%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Progyny's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,221 shares on Aug 31, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Anevski 2026 South Dakota Ngcg Tr Director, Officer | Nov 10, 2026 | 50,139 | $1.80M | Nov 10, 2026 | Restricted Stock Units, Performance Stock Units and Employee Stock Purchase Plan |
| David J. Schlanger Director, Officer | Nov 5, 2026 | 200,000 | $6.02M | Nov 5, 2026 | Exercise of Stock Options |
| Anevski 2026 South Dakota Ngcg Tr Director, Officer | Nov 5, 2026 | 90,000 | $2.71M | Nov 5, 2026 | Restricted Stock Units, Performance Stock Units and Employee Stock Purchase Plan |
| Peter Anevski Director, Officer | Nov 5, 2026 | 314,738 | $9.47M | Nov 5, 2026 | Exercise of Stock Options |
| Mark S. Livingston Officer | Nov 4, 2026 | 2,139 | $64.17K | Nov 4, 2026 | Restricted Stock Vesting |
| Melissa B. Cummings Officer | Oct 14, 2026 | 1,879 | $52.61K | Oct 14, 2026 | Restricted Stock Vesting |
| Allison Swartz Officer | Sep 23, 2026 | 3,903 | $101.87K | Sep 23, 2026 | Restricted Stock Vesting |
| Kevin K. Gordon Director | Sep 10, 2026 | 11,500 | $311.86K | Sep 10, 2026 | Stock Option Exercise |
| Melissa B. Cummings Officer | Jul 14, 2026 | 2,244 | $70.91K | Jul 14, 2026 | Restricted Stock Vesting |
| Mark S. Livingston Officer | Jun 4, 2026 | 2,517 | $64.18K | Jun 4, 2026 | Restricted Stock Vesting |
| Allison Swartz Officer | Jun 4, 2026 | 599 | $15.02K | Jun 4, 2026 | Restricted Stock Vesting |
| Allison Swartz Officer | Jun 3, 2026 | 1,199 | $30.00K | Jun 3, 2026 | Restricted Stock Vesting |
| Mark S. Livingston Officer | Jun 2, 2026 | 279 | $7.31K | Jun 2, 2026 | Restricted Stock Vesting |
| Geoffrey Clapp Officer | Jun 2, 2026 | 1,530 | $39.14K | Jun 2, 2026 | Stock Option Exercise |
| Cheryl Scott Director | Jun 1, 2026 | 7,439 | $196.28K | Jun 1, 2026 | Option Granted - 10/24/2019 |
See a number that looks wrong?